¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦

û¶óÇѾà´ÙÀ̾îÆ® ÇÑÀÇ¿ø Ãʱ⿡ ÀâÀÚ

ÃßõÇϱâ
ÇÑÀÇ¿ø À̹øÁÖ BEST
 
#û¶óÇѾà´ÙÀ̾îÆ®, #û¶óÇѾà´ÙÀ̾îÆ®ÇÑÀÇ¿ø, #Çѹæ´ÙÀ̾îÆ®ÇÑÀÇ¿ø, #û¶óÇѹæ´ÙÀ̾îÆ®ÇÑÀÇ¿ø, #ÇѾà´ÙÀ̾îÆ®ÇÑÀÇ¿ø, #Çѹæ´ÙÀ̾îÆ®ÇÑÀÇ¿øÇÑÀÇ¿ø, #û¶óÇѹæ´ÙÀ̾îÆ®ÇÑÀÇ¿ø, #½ÃÈïÇѾà´ÙÀ̾îÆ® û¶óÇѾà´ÙÀ̾îÆ®,,û¶óÇѾà´ÙÀ̾îÆ®ÇÑÀÇ¿ø,,Çѹæ´ÙÀ̾îÆ®ÇÑÀÇ¿ø,,û¶óÇѹæ´ÙÀ̾îÆ®ÇÑÀÇ¿ø,,ÇѾà´ÙÀ̾îÆ®ÇÑÀÇ¿ø,,Çѹæ´ÙÀ̾îÆ®ÇÑÀÇ¿øÇÑÀÇ¿ø,,û¶óÇѹæ´ÙÀ̾îÆ®ÇÑÀÇ¿ø,,½ÃÈïÇѾà´ÙÀ̾îÆ® ¾È³çÇϼ¼¿ä. û¶óÇѾà´ÙÀ̾îÆ® ½ÃÈï ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä û¶óÇѾà´ÙÀ̾îÆ® ½ÃÈï Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø û¶óÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´ÂÇѹæ´ÙÀ̾îÆ®ÇÑÀÇ¿ø, ÇѾà´ÙÀ̾îÆ®, °Ç°­ÇÑ´ÙÀ̾îÆ®, ºñ¸¸´ÙÀ̾îÆ®, Çѹæ´ÙÀ̾îÆ®, ´ÙÀ̾îÆ®, ´ÙÀ̾îƮȯ, ºñ¸¸´ÙÀ̾îÆ®, »ìºüÁö´ÂÇѾà, »ìºüÁö´ÂÇѾà, ½Ä¿å¾ïÁ¦Á¦, °Ç°­ÇÑ´ÙÀ̾îÆ®, ½Ä¿å¾ïÁ¦Á¦Ã³¹æ, »êÈÄ´ÙÀ̾îÆ®, Çѹæ´ÙÀ̾îÆ®ÇѾà, ´ÙÀ̾îÆ®ÇѾàÇÑÀÇ¿ø, ½Ä¿å¾ïÁ¦Á¦Ã³¹æ, Çѹæ´ÙÀ̾îÆ®ÇѾà, ÇѾà´ÙÀ̾îÆ®, ½Ä¿å¾ïÁ¦ÇѾà, ´ÙÀ̾îÆ®, üÁú°³¼±´ÙÀ̾îÆ®, ´ÙÀ̾îÆ®ÇѾàÇÑÀÇ¿ø, Çѹæ´ÙÀ̾îÆ®ÇÑÀÇ¿ø, ´ÙÀ̾îÆ®ÇѾàµî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó LASER, »ê»ï¾àħ, ³Ã¿Â¿å, silver spike point, ÀÚ¼®¿ä¹ý, ¼öÁöħ, ±â´ÉÀûÀü±âÀÚ±ØÄ¡·á, traction, üÁö¹æÃøÁ¤, ½ÉºÎÈÆÁõ°æ¶ô¾àÂò¿ä¹ý, ¾È¸éÁ¤Çüħ¼ú, ¿äõÃßÃß³ª, °æ±Ù°£¼·ÀúÁÖÆÄ, ¹è³óÄ¡·á, º¹Àâ¿îµ¿Ä¡·á, ÂÁö¾Ê´Âħġ·á, ·Ñ¸µ, EST, º¹Àâ±³Á¤Ãß³ª, ·¹ÀÌÀú, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù ¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼­ Áø·áÁßÀÌ¸ç °­¿ø Źé½Ã Å뵿, °æ±â Àǿսà ³»¼Õ1µ¿, Ãæ³² ¿¹»ê±º ´ë¼ú¸é, °æ³² Å뿵½Ã Ç׳²µ¿, °æ³² â¿ø½Ã ÀÇⱸ ÅðÃ̵¿, ºÎ»ê ºÏ±¸ ¸¸´öµ¿, °æºÏ ¼ºÁÖ±º º®Áø¸é, Àü³² ¸ñÆ÷½Ã Áßµ¿1°¡, ÃæºÏ ÃæÁֽà ±³Çö2µ¿, °æºÏ »óÁֽà ¼ºÇϵ¿, ºÎ»ê ±ÝÁ¤±¸ ºÎ°î4µ¿, °æ³² â¿ø½Ã ¸¶»êÇÕÆ÷±¸ À屺µ¿2°¡, °æ±â ¾È¼º½Ã ¹Ì¾ç¸é, °æºÏ °í·É±º °³Áø¸é, ºÎ»ê ¼­±¸ Å伺µ¿2°¡, °æ±â ¾È¾ç½Ã ¸¸¾È±¸ ¼­¾È¾ç¿ìü±¹»ç¼­ÇÔ, Àü³² °­Áø±º Ä¥·®¸é, Àü³² Áøµµ±º °í±º¸é, Àü³² ¸ñÆ÷½Ã º¹¸¸µ¿, ÀÎõ Áß±¸ ¼ÛÇе¿3°¡, Àü³² ³ªÁֽà ³²ÆòÀ¾, ÀüºÏ ÀÍ»ê½Ã ¼º´ç¸é, °æºÏ ¿µÃµ½Ã ¸ÁÁ¤µ¿, ÀüºÏ ±º»ê½Ã ¹ÌÀ嵿, °­¿ø Á¤¼±±º ¿©·®¸é, ºÎ»ê ¿µµµ±¸ µ¿»ïµ¿, ÀÎõ °è¾ç±¸ µÏ½Çµ¿, ºÎ»ê »ç»ó±¸ ±¥¹ýµ¿, °æ±â ½ÃÈï½Ã µµÃ¢µ¿, °æ³² ÇԾ籺 ÈÞõ¸é, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼­ ³»¿øÇÏ°í °è½Ê´Ï´Ù û¶óÇѾà´ÙÀ̾îƮġ·á ãÀ¸½Ã´Â °Ë¾Ï, ¼Ûµµ, ºñºÀ¸é, ³²±¸, »óµ¿, ³²¾çÀ¾, Áß±¸, ¼Ò·¡Æ÷±¸, µ¿Ãᵿ, ¼­Ã¢µ¿, °ü±³µ¿, ¼Û»ê¸é, ÀÎõ¼­±¸, ÆÈź¸é, ´ëºÎµµ, ¹®Çе¿, Á־ȿª, °è¾ç±¸, ºÀ´ãÀ¾, ¿î³²µ¿, ¿¬¼ö±¸, ¹è°ð½Åµµ½Ã, ¿µÈïµµ, ¿ëÀ¯µµ, °£¼®µ¿, ÇÐÀ͵¿, ½ÃÈï, °è»êµ¿, ¸Å¼Û¸é, ¼Û¸²µ¿, µ¿ÀÎõ, ¿î¼­µ¿, À²¸ñµ¿, ½ÃÈ­, µµ¸²µ¿ µî û¶ó Áö¿ª Áֹε鲲¼­ ¹Ì¿ÃÇÑÀÇ¿øû¶óÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù. ´õ »ìÆ캸±â 1. Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation 2014; 129:S102. 2. Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009; 374:1677. 3. Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ 2013; 347:f5934. 4. Arterburn DE, O'Connor PJ. A look ahead at the future of diabetes prevention and treatment. JAMA 2012; 308:2517. 5. Klein S, Fontana L, Young VL, et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 2004; 350:2549. 6. Leblanc ES, O'Connor E, Whitlock EP, et al. Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2011; 155:434. 7. Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med 2013; 273:219. 8. Sjöström L. Bariatric surgery and reduction in morbidity and mortality: experiences from the SOS study. Int J Obes (Lond) 2008; 32 Suppl 7:S93.
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" û¶óÇѾà´ÙÀ̾îÆ® ÇÑÀÇ¿ø Ãʱ⿡ ÀâÀÚ""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÀÎõÁ¶±âÆó°æ ¼Ûµµ¿©¼ºÇÑÀÇ¿ø Ä¡·á ¾ß°£¿¡µµ
´ÙÀ½±Û ÀÎõ°ú¹Î¼º¹æ±¤ ÇÑÀÇ¿ø ÁÖ¸»Áø·á
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
952 ´ÙÀ̾îÆ®ÇÑÀÇ¿ø »õÇØ À̺¥Æ® ÁøÇà ´ÙÀ̾îÆ®ÇÑ¾à ±¸ÀÔ Æ÷ÀÎÆ® Á¦°ø 0 144 2024-01-15
951 ÀÌõ±³Åë»ç°íÇÑÀÇ¿ø Ãʱ⠰ü¸®·Î ÈÄÀ¯Áõ ¿¹¹æÇØ¿ä 3 390 2023-10-14
950 ÆíµÎÅë ¿¹¹æ¾à ó¹æ, ÁøÅëÁ¦¿Í ÇѾà Ä¡·á ¾Ë¾Æº¸±â 0 374 2023-10-13
949 ¸Þ´Ï¿¡¸£º´ Áø´Ü ¹Þ¾Ò´Ù¸é ¾çÀç µÎûÇÑÀÇ¿øÀ¸·Î 0 415 2023-10-13
948 »êº»±³Åë»ç°íÇÑÀÇ¿ø Ä¡·á¸¸Á·µµ ³ôÀº ÀÌÀ¯ 0 564 2023-08-18
947 â¿ø ÇѾàÀßÁþ´Â°÷ À¯¾Ø¹ÌÇÑÀÇ¿ø 2 865 2023-06-02
946 [ÆíµÎÅëÄ®·³2ź]µÎûÇÑÀÇ¿ø, ÆíµÎÅëÀÌ Ä¡·á°¡ ¾ÈµÇ´Â ÀÌÀ¯ 0 695 2023-05-23
945 [ÆíµÎÅëÄ®·³1ź]µÎûÇÑÀÇ¿ø, ÆíµÎÅëÀ» ¾Î´ø ÇÑÀÇ»ç ÆíµÎÅëÀ» ¿ÏÄ¡ÇÏ´Ù 3 733 2023-05-19
944 â¿ø ¸¶»ê ´ß»ìÇǺΠ¸ð°ø°¢È­Áõ ÇÑÀÇ¿ø Ä¡·á·Î ½Î¾Ç~ 2 724 2023-05-11
943 ºÎ»ê¼­¸é´ÙÀ̾îÆ®ÇÑÀÇ¿ø »ýÈ°°Ç°­ÇÑÀÇ¿ø 5¿ù °¡Á¤ÀÇ´Þ Æ¯°¡À̺¥Æ® ½ÃÀÛ.. 3 949 2023-05-10
942 ±¸¿ùµ¿ÇÑÀÇ¿ø °æÈñÀÚ¶õÇÑÀÇ¿ø¿¡¼­ ´ÙÀ̾îÆ® ±³Åë»ç°í Ãß³ª¿ä¹ý ÀÎõ ³².. 2 861 2023-05-10
941 â¿ø´ÙÀ̾îÆ®ÇÑÀÇ¿ø, â¿ø´ÙÀ̾îƮȯ À¯¾Ø¹ÌÇÑÀÇ¿ø ½½¸²È¯ 2 845 2023-04-20
940 ûÁÖ º¹´ëµ¿ ÇÑÀÇ¿ø, ¸¶À½¿¡²ÉÇÑÀÇ¿ø º½¸ÂÀÌ À̺¥Æ® 18 946 2023-04-19
939 ¿µµîÆ÷ÇÑÀÇ¿ø ¼±ÇÑÀÇ¿ø Áñ°Å¿ö º½ À̺¥Æ® 14 835 2023-04-19
938 â¿ø ¸¶»ê ´ÙÀ̾îƮȯ À¯¾Ø¹ÌÇÑÀÇ¿ø 12 1,263 2023-03-20
937 â¿ø ¸¶»ê»êÈĺ¸¾à Çѹ泻°úÀü¹®ÀÇ °Ç°­ÇÑ È¸º¹ 14 1,048 2023-02-02
936 [¶óÀ²ÇÑÀÇ¿ø] º½À» ±â´Ù¸®´Â 2¿ù À̺¥Æ® 0 1,219 2023-02-02
935 ÇØ¿ÂÇÑÀÇ¿ø ¼³³¯À̺¥Æ® °øÁø´Ü °æ¿Á°í ½ÖÈ­ÅÁ ÇýÅà (~1/31) 1 941 2023-01-10
934 ÇÏÀÌÅ°ÇÑÀÇ¿ø 1¿ù À̺¥Æ® ¾È³» 0 1,110 2023-01-03
933 ¸¶ÀÌÇÃÇÑÀÇ¿ø ¿¬¸» °¨»ç À̺¥Æ® 0 1,479 2022-12-09
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷